New cocktail of drugs shows promise against tough head and neck cancer

NCT ID NCT05459129

Completed Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 28 times

Summary

This study tested several drug combinations in 12 people with advanced head and neck cancer that had not been treated yet. The goal was to see if the drugs could make the tumors disappear before surgery. The study is complete, and results help guide future treatment options.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Asan Medical Center

Seoul, 05505, South Korea
City of Hope

Duarte, California, 91010, United States
Hadassah University Hospital - Ein Kerem

Jerusaelm, 9112001, Israel
Severance Hospital - Yonsei Cancer Center

Seoul, 03722, South Korea
Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107, United States
University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Conditions

Explore the condition pages connected to this study.

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK